RhumbLine Advisers’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Sell |
|
|||||
|
2025
Q1 | $23M | Buy |
|
|||||
|
2024
Q4 | $10.1M | Sell |
|
|||||
|
2024
Q3 | $9.39M | Buy |
|
|||||
|
2024
Q2 | $6.59M | Sell |
|
|||||
|
2024
Q1 | $5.21M | Sell |
|
|||||
|
2023
Q4 | $6.9M | Buy |
|
|||||
|
2023
Q3 | $5.59M | Buy |
|
|||||
|
2023
Q2 | $4.56M | Sell |
|
|||||
|
2023
Q1 | $4.57M | Buy |
|
|||||
|
2022
Q4 | $4.02M | Buy |
|
|||||
|
2022
Q3 | $5.04M | Buy |
|
|||||
|
2022
Q2 | $4.44M | Buy |
|
|||||
|
2022
Q1 | $4.09M | Buy |
|
|||||
|
2021
Q4 | $3.54M | Sell |
|
|||||
|
2021
Q3 | $3.54M | Sell |
|
|||||
|
2021
Q2 | $4.83M | Sell |
|
|||||
|
2021
Q1 | $5.32M | Buy |
|
|||||
|
2020
Q4 | $5.7M | Buy |
|
|||||
|
2020
Q3 | $3.79M | Sell |
|
|||||
|
2020
Q2 | $4.04M | Sell |
|
|||||
|
2020
Q1 | $3.02M | Buy |
|
|||||
|
2019
Q4 | $3.05M | Buy |
|
|||||
|
2019
Q3 | $3.29M | Buy |
|
|||||
|
2019
Q2 | $2.59M | Buy |
|
|||||
|
2019
Q1 | $2.68M | Sell |
|
|||||
|
2018
Q4 | $3.09M | Buy |
|
|||||
|
2018
Q3 | $2.58M | Buy |
|
|||||
|
2018
Q2 | $2.88M | Buy |
|
|||||
|
2018
Q1 | $2.82M | Buy |
|
|||||
|
2017
Q4 | $3.04M | Buy |
|
|||||
|
2017
Q3 | $1.73M | Buy |
|
|||||
|
2017
Q2 | $1.03M | Buy |
|
|||||
|
2017
Q1 | $791K | Buy |
|
|||||
|
2016
Q4 | $506K | Buy |
|
|||||
|
2016
Q3 | $390K | Buy |
|
|||||
|
2016
Q2 | $310K | Buy |
|
|||||
|
2016
Q1 | $227K | Sell |
|
|||||
|
2015
Q4 | $242K | Buy |
|
|||||
|
2015
Q3 | $165K | Buy |
|
|||||
|
2015
Q2 | $251K | Sell |
|
|||||
|
2015
Q1 | $243K | Buy |
|
|||||
|
2014
Q4 | $100K | Sell |
|
|||||
|
2014
Q3 | $112K | Hold |
|
|||||
|
2014
Q2 | $117K | Sell |
|
|||||
|
2014
Q1 | $190K | Sell |
|
|||||
|
2013
Q4 | $148K | Sell |
|
|||||
|
2013
Q3 | $74K | Sell |
|
|||||
|
2013
Q2 | $81K | Buy |
|